`
`
`
`
`Apotex Products United States
`
` Updated April 29, 2020
`
`
`
`www.apotexcorp.com/products
`
`
`
`
`
`CIPLA LTD. EXHIBIT 2004 PAGE 1
`
`

`

`Apotex Products United States
`
`
`
`UNITED STATES OFFICE
`Apotex Corp.
`2400 North Commerce Parkway, Suite 400
`Weston, Florida 33326
`Toll Free: 1-800-706-5575
`Toll Free Fax: 1-800-706-5576
`www.apotexcorp.com
`Email: UScustomerservice@apotex.com
`
`DISpedia
`DRUG INFORMATION SERVICE
`Toll Free: 1-800-667-4708
`Email: dispedia@apotex.com
`
`This page was last updated on April 29, 2020. Maintained by Apotex Groups of Companies.
`
`Copyright © 2020, Apotex Groups of Companies. All rights reserved. Products listed in this catalogue are only available for sale in United States.
`
`SWP prices shown are subject to change. All brand or product names are trademarks of their respective holders.
`
`STANDARD RETURNS POLICY
`Effective: February 1, 2012
`
`RETURNABLE ITEMS
`• Products must be in the original, sealed Apotex labeled containers or original, sealed containers as distributed by Apotex.
`• Apotex will accept product up to six (6) months before expiration date and up to six (6) months after the expiration date.
`• All returns are subject to approval.
`• This policy is subject to the laws within the governing jurisdiction of the customer.
`
`NON-RETURNABLE ITEMS
`• Products with more than six (6) months remaining shelf life OR more than six (6) months beyond expiration date.
`• Repackaged goods, partials, free goods, samples, short-dated items sold as such, items sold on a non-returnable basis, or product that is not sent to Genco Pharmaceuticals
`for processing.
`• Products missing label or lot number and expiration date.
`• Products damaged due to insurable causes such as fire or natural disasters, or if damaged/deteriorated due to improper handling or storage by the customer.
`• Merchandise remaining after a bankruptcy or distress sale.
`• Merchandise purchased or distributed contrary to federal, state or local laws.
`
`SHIPPING ERRORS/DAMAGES
`Overstock, miss-shipments, damages, and shortage(s) must be reported to the Apotex Corp. Customer Service Department: (877) 427-6839 or Fax (800) 706-5576,
`within 10 days of receipt of the order for pre-authorization and credit eligibility. Apotex reserves the right to verify claims of shortages against shipping records.
`
`RETURN PRICING
`Currently on Contract?
`
`Indirect
`
`Direct
`
`YES
`
`Direct Contract Price
`
`Indirect Contract Price
`
`NO, but was in the past 24 months
`
`Direct Contract Price less any billbacks, rebates or
`administration fees
`
`Indirect Contract Price less any billbacks, rebates
`or administration fees
`
`No Credit
`
`See Indirect column
`
`NO, and was not in the past 24 months
`
`DISCLAIMERS
`• Apotex Corp does not pay or reimburse fees incurred for the processing of or destruction of products processed through a third party returns processing company.
`• Apotex Corp reserves the right to change or update this policy upon written notice to customers.
`• Products that do not qualify for credit or reimbursement will be destroyed and not returned to the customer. Customer will be invoiced for the costs of the processing and
`destruction of these products.
`
`PROCEDURE FOR RETURNING ITEMS
`• Products MUST be returned to Genco Pharmaceuticals in order to receive credit.
`• Please do not make any deductions from remittances in anticipation of credit.
`• All returns must be arranged and prepaid by Customer.
`• All returns excluding products damaged in transit must be returned to the following address: GENCO Pharmaceutical Services, Apotex Corp. Returns, 6101 North 64th
`Street, Milwaukee, WI 53218 Telephone: (414) 967-2800
`• For shipping errors and damaged product, please see above section, "Shipping Errors/Damages".
`• A DEA Form 222 is required in order to return C-II controlled substance. Please send DEA Form 222 requests to: Fax (414) 459-8702 or E-mail:
`mfgr222requests@gencopharma.com
`• Customers who do not have direct contracts in place with Apotex must return product to the wholesaler/distributor from which they purchased the product. Credit will be
`issued through such wholesaler/distributor.
`
`
`
`
`
`www.apotexcorp.com/products
`
`
`
`
`
`CIPLA LTD. EXHIBIT 2004 PAGE 2
`
`

`

`
`
`
`
`Apotex Products United States
`
` Updated April 29, 2020
`
` New Products
`
` All Products
`
`
`
`Injectable Products
`
` Specialty Products
`
`1
`
`2
`
`40
`
`45
`
`CIPLA LTD. EXHIBIT 2004 PAGE 3
`
`

`

`Apotex Products United States
`
`Updated April 29, 2020 New Products
`
`Product Name
`(Active Ingredients)
`
` Strength
`
` Brand Reference TE
`Rating
`
` Image
`(Not to Scale)
`
` NDC Number
`
` Pack Size
`
`
`
`
`Azelastine Hydrochloride and
`Fluticasone Propionate Nasal Spray
`(Azelastine Fluticasone)
`
` 137MCG/50MCG DYMISTA®
`
` AB
`
`Cyclosporine Capsules
`(Cyclosporine)
`
` 25MG
`
` NEORAL®
`
` AB1
`
` 50MG
`
` NEORAL®
`
` AB1
`
` 100MG
`
` NEORAL®
`
` AB1
`
`Paroxetine CR Tablets
`(Paroxetine Hydrochloride)
`
` 12.5MG
`
` PAXIL® CR
`
`
`
` PAXIL® CR
`
` 25MG
`
` PAXIL® CR
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 60505-0953-03
`
` 120MS NASAL SPRAY
`
` 60505-4630-03
`
` 30 LIQUID GEL
`CAPSULES UD
`
` 60505-4631-03
`
` 30 LIQUID GEL
`CAPSULES UD
`
` 60505-4632-03
`
` 30 LIQUID GEL
`CAPSULES UD
`
`photo not
`available
`
` 60505-1316-03
`
` 30 TABLET
`
` 60505-1316-03
`
` 30 TABLET
`
` 60505-1317-03
`
` 30 TABLET
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` PAXIL® CR
`
`Paxil CR Tablets
`(Paroxetine Hydrochloride)
`
` 37.5MG
`
` N/A
`
`
`
`
`
`Sirolimus Oral Solution
`(Sirolimus)
`
`Tetrabenazine Tablets
`(Tetrabenazine)
`
` 1MG/ML
`
` RAPAMUNE®
`
` AA
`
` 12.5MG
`
` XENAZINE®
`
` 25MG
`
` XENAZINE®
`
` AB
`
` AB
`
`Travoprost Ophthalmic Solution
`(Travoprost)
`
` 0.004%
`
` TRAVATAN® Z
`
` AT
`
`
`
` TRAVATAN® Z
`
` AT
`
`photo not
`available
`photo not
`available
`
`photo not
`available
`
`photo not
`available
`
`photo not
`available
`
`photo not
`available
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 60505-1317-03
`
` 30 TABLET
`
` 60505-4379-03
`
` 30 TABLET
`
` 60505-6197-02
`
` 60ML ORAL
`SOLUTION
`
` 60505-3882-07
`
` 112 TABLET
`
` 60505-3883-07
`
` 112 TABLET
`
` 60505-0593-04
`
` 2.5ML OPHTHALMIC
`SOLUTION
`
` 60505-0593-01
`
` 5ML OPHTHALMIC
`SOLUTION
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`www.apotexcorp.com/products
`
`1
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`CIPLA LTD. EXHIBIT 2004 PAGE 4
`
`

`

`Apotex Products United States
`
`Updated April 29, 2020 All Products
`
`Product Name
`(Active Ingredients)
`
` Strength
`
` Brand Reference TE
`Rating
`
` Image
`(Not to Scale)
`
` NDC Number
`
` Pack Size
`
`Abacavir Sulfate Tablets
`(Abacavir)
`
` 300MG
`
` ZIAGEN®
`
` AB
`
`Abiraterone Acetate Tablets
`(Abiraterone)
`
` 250MG
`
` ZYTIGA®
`
` AB
`
`
`
` ZYTIGA®
`
`Acyclovir Capsules USP
`(Acyclovir)
`
` 200MG
`
` ZOVIRAX®
`
` AB
`
` AB
`
`
`
` ZOVIRAX®
`
` AB
`
`Acyclovir Tablets USP
`(Acyclovir)
`
` 400MG
`
` ZOVIRAX®
`
` AB
`
`
`
`
`
` ZOVIRAX®
`
` ZOVIRAX®
`
` AB
`
` AB
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 60505-3583-06
`
` 60 TABLET
`
` 60505-4327-01
`
` 120 TABLET
`
`photo not
`available
`
` 60505-4327-01
`
` 120 TABLET
`
` 60505-0042-06
`
` 100 CAPSULE
`
` 60505-0042-06
`
` 100 CAPSULE
`
` 60505-5306-01
`
` 100 TABLET
`
`photo not
`available
`
` 60505-5306-01
`
` 100 TABLET
`
` 60505-5306-08
`
` 1000 TABLET
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` ZOVIRAX®
`
` 800MG
`
` ZOVIRAX®
`
`
`
`
`
`
`
` ZOVIRAX®
`
` ZOVIRAX®
`
` ZOVIRAX®
`
`Adefovir Dipivoxil Tablets
`(Adefovir Dipivoxil)
`
` 10MG
`
` HEPSERA®
`
` AB
`
` AB
`
` AB
`
` AB
`
` AB
`
` AB
`
`Alfuzosin Hydrochloride Extended-
`Release Tablets
`(Alfuzosin Hydrochloride)
`
`Amlodipine and Olmesartan
`Medoxomil Tablets
`(Amlodipine Olmesartan)
`
` 10MG
`
` UROXATRAL®
`
` AB
`
` 5MG/20MG
`
` AZOR®
`
` AB
`
` 5MG/40MG
`
` AZOR®
`
` AB
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`photo not
`available
`
`photo not
`available
`
`photo not
`available
`
` 60505-5306-08
`
` 1000 TABLET
`
` 60505-5307-01
`
` 100 TABLET
`
` 60505-5307-01
`
` 100 TABLET
`
` 60505-5307-05
`
` 500 TABLET
`
` 60505-5307-05
`
` 500 TABLET
`
` 60505-3947-03
`
` 30 TABLET
`
` 60505-2850-01
`
` 100 TABLET
`
` 60505-4582-03
`
` 30 TABLET
`
` 60505-4583-03
`
` 30 TABLET
`
`www.apotexcorp.com/products
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`2
`
`CIPLA LTD. EXHIBIT 2004 PAGE 5
`
`

`

`Apotex Products United States
`
`Updated April 29, 2020 All Products
`
`Product Name
`(Active Ingredients)
`
` Strength
`
` Brand Reference TE
`Rating
`
` Image
`(Not to Scale)
`
` NDC Number
`
` Pack Size
`
` 10MG/40MG
`
` AZOR®
`
` AB
`
`Anastrozole Tablets
`(Anastrozole)
`
` 1MG
`
` ARIMIDEX®
`
` AB
`
`Aripiprazole Oral Solution
`(Aripiprazole)
`
` 1MG/ML
`
` ABILIFY®
`
` AA
`
`Aripiprazole Tablets
`(Aripiprazole)
`
` 2MG
`
` ABILIFY®
`
` AB
`
`
`
`
`
`
`
` ABILIFY®
`
` AB
`
` ABILIFY®
`
` AB
`
` AB
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 60505-4585-03
`
` 30 TABLET
`
` 60505-2985-03
`
` 30 TABLET
`
` 60505-0404-05
`
` 150ML ORAL
`SOLUTION
`
` 60505-3075-03
`
` 30 TABLET
`
` 60505-3075-03
`
` 30 TABLET
`
` 60505-3075-08
`
` 1000 TABLET
`
` 60505-3075-08
`
` 1000 TABLET
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` ABILIFY®
`
` 5MG
`
` ABILIFY®
`
` AB
`
`
`
`
`
`
`
` ABILIFY®
`
` AB
`
` ABILIFY®
`
` AB
`
` ABILIFY®
`
` AB
`
` 10MG
`
` ABILIFY®
`
` AB
`
`
`
`
`
`
`
` ABILIFY®
`
` AB
`
` ABILIFY®
`
` AB
`
` ABILIFY®
`
` AB
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`www.apotexcorp.com/products
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 60505-2673-03
`
` 30 TABLET
`
` 60505-2673-03
`
` 30 TABLET
`
` 60505-2673-08
`
` 1000 TABLET
`
` 60505-2673-08
`
` 1000 TABLET
`
` 60505-2674-03
`
` 30 TABLET
`
` 60505-2674-03
`
` 30 TABLET
`
` 60505-2674-08
`
` 1000 TABLET
`
` 60505-2674-08
`
` 1000 TABLET
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`3
`
`CIPLA LTD. EXHIBIT 2004 PAGE 6
`
`

`

`Apotex Products United States
`
`Updated April 29, 2020 All Products
`
`Product Name
`(Active Ingredients)
`
` Strength
`
` Brand Reference TE
`Rating
`
` Image
`(Not to Scale)
`
` NDC Number
`
` Pack Size
`
` 15MG
`
` ABILIFY®
`
` AB
`
`
`
`
`
`
`
` ABILIFY®
`
` AB
`
` ABILIFY®
`
` AB
`
` ABILIFY®
`
` AB
`
` 20MG
`
` ABILIFY®
`
` AB
`
` ABILIFY®
`
` AB
`
` ABILIFY®
`
` AB
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 60505-2675-03
`
` 30 TABLET
`
` 60505-2675-03
`
` 30 TABLET
`
` 60505-2675-08
`
` 1000 TABLET
`
` 60505-2675-08
`
` 1000 TABLET
`
` 60505-2676-03
`
` 30 TABLET
`
` 60505-2676-03
`
` 30 TABLET
`
` 60505-2676-08
`
` 1000 TABLET
`
` 1000 TABLET
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` ABILIFY®
`
` AB
`
` 60505-2676-08
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 30MG
`
` ABILIFY®
`
` AB
`
`
`
`
`
`
`
` ABILIFY®
`
` AB
`
` ABILIFY®
`
` AB
`
` ABILIFY®
`
` AB
`
`Atomoxetine Capsules
`(Atomoxetine Hydrochloride)
`
` 10MG
`
` STRATTERA®
`
` AB
`
`
`
` STRATTERA®
`
` AB
`
` 18MG
`
` STRATTERA®
`
` AB
`
`
`
` STRATTERA®
`
` AB
`
`www.apotexcorp.com/products
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 60505-2677-03
`
` 30 TABLET
`
` 60505-2677-03
`
` 30 TABLET
`
` 60505-2677-08
`
` 1000 TABLET
`
` 60505-2677-08
`
` 1000 TABLET
`
` 60505-2830-03
`
` 30 CAPSULE
`
` 60505-2830-03
`
` 30 CAPSULE
`
` 60505-2831-03
`
` 30 CAPSULE
`
` 60505-2831-03
`
` 30 CAPSULE
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`4
`
`CIPLA LTD. EXHIBIT 2004 PAGE 7
`
`

`

`Apotex Products United States
`
`Updated April 29, 2020 All Products
`
`Product Name
`(Active Ingredients)
`
` Strength
`
` Brand Reference TE
`Rating
`
` Image
`(Not to Scale)
`
` NDC Number
`
` Pack Size
`
` 25MG
`
` STRATTERA®
`
` AB
`
`
`
` STRATTERA®
`
` AB
`
` 40MG
`
` STRATTERA®
`
` AB
`
`
`
` STRATTERA®
`
` AB
`
` 60MG
`
` STRATTERA®
`
` AB
`
`
`
` STRATTERA®
`
` AB
`
` 80MG
`
` STRATTERA®
`
` AB
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 60505-2832-03
`
` 30 CAPSULE
`
` 60505-2832-03
`
` 30 CAPSULE
`
` 60505-2833-03
`
` 30 CAPSULE
`
` 60505-2833-03
`
` 30 CAPSULE
`
` 60505-2834-03
`
` 30 CAPSULE
`
` 60505-2834-03
`
` 30 CAPSULE
`
` 60505-2835-03
`
` 30 CAPSULE
`
` 30 CAPSULE
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` STRATTERA®
`
` AB
`
` 60505-2835-03
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 100MG
`
` STRATTERA®
`
` AB
`
`
`
` STRATTERA®
`
` AB
`
`Atorvastatin Calcium Tablets
`(Atorvastatin Calcium)
`
` 10MG
`
` LIPITOR®
`
` AB
`
`
`
` LIPITOR®
`
` AB
`
` 20MG
`
` LIPITOR®
`
` AB
`
`
`
` LIPITOR®
`
` AB
`
` 40MG
`
` LIPITOR®
`
` AB
`
`
`
` LIPITOR®
`
` AB
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`www.apotexcorp.com/products
`
` 60505-2836-03
`
` 30 CAPSULE
`
` 60505-2836-03
`
` 30 CAPSULE
`
` 60505-2578-09
`
` 90 TABLET
`
` 60505-2578-08
`
` 1000 TABLET
`
` 60505-2579-09
`
` 90 TABLET
`
` 60505-2579-08
`
` 1000 TABLET
`
` 60505-2580-09
`
` 90 TABLET
`
` 60505-2580-08
`
` 1000 TABLET
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`5
`
`CIPLA LTD. EXHIBIT 2004 PAGE 8
`
`

`

`Apotex Products United States
`
`Updated April 29, 2020 All Products
`
`Product Name
`(Active Ingredients)
`
` Strength
`
` Brand Reference TE
`Rating
`
` Image
`(Not to Scale)
`
` NDC Number
`
` Pack Size
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 80MG
`
` LIPITOR®
`
` AB
`
`
`
` LIPITOR®
`
` AB
`
`Azelastine HCl Nasal Solution
`(Nasal Spray)
`(Azelastine)
`
` 0.15%
`
` ASTEPRO®
`
` AB
`
`Azelastine Hydrochloride and
`Fluticasone Propionate Nasal Spray
`(Azelastine Fluticasone)
`
` 137MCG/50MCG DYMISTA®
`
` AB
`
`Azelastine Hydrochloride Nasal
`Solution
`(Azelastine)
`
` 137MCG
`
` ASTELIN®
`
` AB
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 60505-2671-09
`
` 90 TABLET
`
` 60505-2671-08
`
` 1000 TABLET
`
` 60505-0848-05
`
` 30ML NASAL SPRAY
`
` 60505-0953-03
`
` 120MS NASAL SPRAY
`
` 60505-0833-05
`
` 30ML NASAL SPRAY
`
` 60505-0578-04
`
`
`
`Azelastine Hydrochloride
`Ophthalmic Solution
`(Azelastine)
`
` 0.05%
`
` OPTIVAR®
`
` AT
`
` 6ML OPHTHALMIC
`SOLUTION
`
`
`
`
`
`
`
`
`
`
`
`
`
`Azithromycin for Injection
`(Azithromycin)
`
` 500MG
`
` ZITHROMAX®
`
` AP
`
`Azithromycin Tablets
`(Azithromycin)
`
` 250MG
`
` ZITHROMAX®
`
` AB
`
`Azithromycin Tablets, USP
`(Azithromycin)
`
` 250MG
`
` ZITHROMAX®
`
` AB
`
` 500MG
`
` ZITHROMAX®
`
` AB
`
`Balsalazide Disodium Capsules
`(Balsalazide Disodium)
`
` 750MG
`
` COLAZAL®
`
` AB
`
`
`
`
`
`
`
`
`
`
`
`www.apotexcorp.com/products
`
` 60505-6076-04
`
` 10X10ML POWDER
`
`
`
` 60505-2581-05
`
` 500 TABLET
`
` 60505-2581-03
`
` 30 TABLET
`
` 60505-2582-03
`
` 30 TABLET
`
` 60505-2575-07
`
` 280 CAPSULE
`
`
`
`
`
`
`
`
`
`6
`
`CIPLA LTD. EXHIBIT 2004 PAGE 9
`
`

`

`Apotex Products United States
`
`Updated April 29, 2020 All Products
`
`Product Name
`(Active Ingredients)
`
` Strength
`
` Brand Reference TE
`Rating
`
` Image
`(Not to Scale)
`
` NDC Number
`
` Pack Size
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Benazepril HCl and
`Hydrochlorothiazide Tablets
`(Benazepril HCL /
`Hydrochlorothiazide)
`
` 5/6.25 MG
`
` LOTENSIN® HCT
`
` AB
`
` 10/12.5MG
`
` LOTENSIN® HCT
`
` AB
`
` 20/12.5MG
`
` LOTENSIN® HCT
`
` AB
`
` 20/25MG
`
` LOTENSIN® HCT
`
` AB
`
`Bimatoprost Ophthalmic Solution
`(Bimatoprost)
`
` 0.03%
`
` LUMIGAN®
`
` AT
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 60505-0261-01
`
` 100 TABLET
`
` 60505-0262-01
`
` 100 TABLET
`
` 60505-0263-01
`
` 100 TABLET
`
` 60505-0264-01
`
` 100 TABLET
`
` 60505-0583-04
`
` 2.5ML OPHTHALMIC
`SOLUTION
`
`
`
` 60505-0583-01
`
`
`
` LUMIGAN®
`
` AT
`
` 5ML OPHTHALMIC
`SOLUTION
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Bivalirudin for Injection
`(Bivalirudin)
`
` 250MG
`
` ANGIOMAX®
`
` AP
`
`Budesonide Nasal Spray
`(Budesonide)
`
` 32MCG
`
` RHINOCORT®
`ALLERGY SPRAY
`
` OTC
`
`Bupropion Hydrochloride Tablets
`(Bupropion HCl)
`
` 75MG
`
` WELLBUTRIN®
`
` AB
`
`
`
` WELLBUTRIN®
`
` AB
`
` 100MG
`
` WELLBUTRIN®
`
` AB
`
`
`
` WELLBUTRIN®
`
` AB
`
`
`
`
`
`
`
`
`
`
`
`
`
`www.apotexcorp.com/products
`
` 60505-6101-04
`
` 1 INJECTABLE
`
`
`
` 60505-6129-02
`
` 120 NASAL SPRAY
`
`
`
` 60505-0158-01
`
` 100 TABLET
`
` 60505-0158-01
`
` 100 TABLET
`
` 60505-0157-01
`
` 100 TABLET
`
` 60505-0157-01
`
` 100 TABLET
`
`
`
`
`
`
`
`
`
`7
`
`CIPLA LTD. EXHIBIT 2004 PAGE 10
`
`

`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Apotex Products United States
`
`Updated April 29, 2020 All Products
`
` Strength
`
` Brand Reference TE
`Rating
`
` Image
`(Not to Scale)
`
` NDC Number
`
` Pack Size
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 60505-6177-08
`
` 8X10ML INJECTABLE
`
` 60505-0813-01
`
` 2.5ML NASAL SPRAY
`
` 60505-0823-06
`
` 3.7ML NASAL SPRAY
`
` 60505-2805-07
`
` 120 CAPSULE
`
` 60505-2805-07
`
` 120 CAPSULE
`
` 60505-2806-07
`
` 120 CAPSULE
`
` 60505-2806-07
`
` 120 CAPSULE
`
`photo not
`available
`
`photo not
`available
`
`
`
`
`
`
`
`
`
`
`
`Product Name
`(Active Ingredients)
`
`Busulfan Injection
`(Busulfan)
`
` 6MG/ML
`
` BUSULFEX®
`
` AP
`
`Butorphanol Tartrate Nasal Spray
`(Butorphanol Tartrate)
`
` 10MG/ML
`
` STADOL® NS
`
` AB
`
`Calcitonin-Salmon Nasal Spray
`(Calcitonin Salmon)
`
` 200IU
`
` MIACALCIN®
`
` AB
`
`Carbamazepine Extended-Release
`Capsules
`(Carbamazepine Controlled
`Release)
`
` 100MG
`
` CARBATROL®
`
` AB
`
`
`
` CARBATROL®
`
` AB
`
` 200MG
`
` CARBATROL®
`
` AB
`
`
`
` CARBATROL®
`
` AB
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 300MG
`
` CARBATROL®
`
` AB
`
`
`
`
`
` CARBATROL®
`
` CARBATROL®
`
`Carbamazepine Tablets USP
`(Carbamazepine)
`
` 200MG
`
` TEGRETOL®
`
` AB
`
` AB
`
` AB
`
`
`
`
`
`
`
` TEGRETOL®
`
` AB
`
` TEGRETOL®
`
` AB
`
` TEGRETOL®
`
` AB
`
`Carvedilol Phosphate Extended-
`Release Capsules
`(Carvedilol)
`
` 10MG
`
` COREG® CR
`
` AB
`
`www.apotexcorp.com/products
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 60505-2807-07
`
` 120 CAPSULE
`
`photo not
`available
`photo not
`available
`
` 60505-2807-07
`
` 120 CAPSULE
`
` 60505-2807-07
`
` 120 CAPSULE
`
` 60505-0183-00
`
` 100 TABLET
`
` 60505-0183-00
`
` 100 TABLET
`
` 60505-0183-01
`
` 1000 TABLET
`
` 60505-0183-01
`
` 1000 TABLET
`
` 60505-3678-03
`
` 30 CAPSULE
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`8
`
`CIPLA LTD. EXHIBIT 2004 PAGE 11
`
`

`

`Apotex Products United States
`
`Updated April 29, 2020 All Products
`
`Product Name
`(Active Ingredients)
`
` Strength
`
` Brand Reference TE
`Rating
`
` Image
`(Not to Scale)
`
` NDC Number
`
` Pack Size
`
`
`
`
`
`
`
`
`
`
` 20MG
`
` COREG® CR
`
` AB
`
` 40MG
`
` COREG® CR
`
` AB
`
` 80MG
`
` COREG® CR
`
` AB
`
`Cefazolin for Injection
`(Cefazolin)
`
` 1G
`
` CEFAZOLIN® FOR
`INJECTION
`
` AP
`
` 10G
`
` ANCEF®
`
` AP
`
`Cefepime for Injection
`(Cefepime)
`
` 1G
`
` MAXIPIME®
`
` AP
`
`
`
`
`
` MAXIPIME®
`
` AP
`
` MAXIPIME®
`
` AP
`
` 2G
`
` MAXIPIME®
`
` AP
`
`
`
` MAXIPIME®
`
` AP
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 60505-3679-03
`
` 30 CAPSULE
`
` 60505-3680-03
`
` 30 CAPSULE
`
` 60505-3681-03
`
` 30 CAPSULE
`
` 60505-6142-05
`
` 25X10ML INJECTABLE
`
` 60505-6143-04
`
` 10X100ML
`INJECTABLE
`
`
`
` 60505-6144-04
`
`
` 10X20ML INJECTABLE
`UD
`
` 60505-6146-04
`
`
` 10X20ML INJECTABLE
`UD
`
` 60505-6146-00
`
` 20ML INJECTABLE
`
`
`
` 60505-6145-04
`
` 10X20ML INJECTABLE
`
`
`UD
`
` 60505-6147-04
`
` 10X20ML INJECTABLE
`
`
`UD
`
`www.apotexcorp.com/products
`
`9
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`CIPLA LTD. EXHIBIT 2004 PAGE 12
`
`

`

`Apotex Products United States
`
`Updated April 29, 2020 All Products
`
`Product Name
`(Active Ingredients)
`
` Strength
`
` Brand Reference TE
`Rating
`
` Image
`(Not to Scale)
`
` NDC Number
`
` Pack Size
`
` 60505-6147-00
`
` 20ML INJECTABLE
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` MAXIPIME®
`
` AP
`
`Ceftriaxone for Injection
`(Ceftriaxone)
`
` 1G
`
` CEFTRIAXONE®
`
` AP
`
` 2G
`
` CEFTRIAXONE®
`
` AP
`
` 250MG
`
` CEFTRIAXONE®
`
` AP
`
`
`
` CEFTRIAXONE®
`
` AP
`
` 500MG
`
` CEFTRIAXONE®
`
` AP
`
`
`
` CEFTRIAXONE®
`
` AP
`
` 10G
`
` ROCEPHIN®
`
` AP
`
`Celecoxib Capsules
`(Celecoxib)
`
` 50MG
`
` CELEBREX®
`
` AB
`
`www.apotexcorp.com/products
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 60505-6148-04
`
` 10X20ML INJECTABLE
`
` 60505-6149-04
`
` 10X20ML INJECTABLE
`
` 60505-6151-04
`
` 10ML INJECTABLE
`
`
`
` 60505-6151-01
`
` 10X10ML INJECTABLE
`
` 60505-6152-04
`
` 10ML INJECTABLE
`
`
`
` 60505-6152-01
`
` 10X10ML INJECTABLE
`
` 60505-6150-05
`
` 100ML POWDER
`
` 60505-3847-06
`
` 60 CAPSULE
`
`
`
`
`
`10
`
`CIPLA LTD. EXHIBIT 2004 PAGE 13
`
`

`

`Apotex Products United States
`
`Updated April 29, 2020 All Products
`
`Product Name
`(Active Ingredients)
`
` Strength
`
` Brand Reference TE
`Rating
`
` Image
`(Not to Scale)
`
` NDC Number
`
` Pack Size
`
` 100MG
`
` CELEBREX®
`
` AB
`
`
`
` CELEBREX®
`
` AB
`
` 200MG
`
` CELEBREX®
`
` AB
`
`
`
` CELEBREX®
`
` AB
`
` 10MG
`
`
`
` 50MG
`
`
`
` ZYRTEC® ALLERGY
`AND ZYRTEC HIVES
`RELIEF
`
` N/A
`
` ZYRTEC® ALLERGY
`AND ZYRTEC HIVES
`RELIEF
` PLETAL®
`
` N/A
`
` AB
`
` AB
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 60505-3848-01
`
` 100 CAPSULE
`
` 60505-3848-05
`
` 500 CAPSULE
`
` 60505-3849-01
`
` 100 CAPSULE
`
` 60505-3849-05
`
` 500 CAPSULE
`
` 60505-2633-01
`
` 100 TABLET
`
` 60505-2633-08
`
` 1000 TABLET
`
` 60505-2521-01
`
` 60 TABLET
`
` 60505-2521-01
`
` 60 TABLET
`
`Cetirizine HCl Tablets
`(Cetirizine Hydrochloride)
`
`Cilostazol Tablets
`(Cilostazol)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` PLETAL®
`
` 100MG
`
` PLETAL®
`
` AB
`
`
`
` PLETAL®
`
`Clofarabine Injection
`(Clofarabine)
`
` 1MG/ML
`
` CLOLAR®
`
` AB
`
` AP
`
`Clopidogrel Tablets
`(Clopidogrel Bisulfate)
`
` 300MG
`
` PLAVIX®
`
` AB
`
`Clopidogrel Tablets USP
`(Clopidogrel Bisulfate)
`
` 75MG
`
` PLAVIX®
`
` AB
`
`
`
`
`
`Cyclobenzaprine Hydrochloride
`Extended-Release Capsules
`(Cyclobenzaprine Hydrochloride)
`
` 15MG
`
` PLAVIX®
`
` AB
`
` PLAVIX®
` AMRIX®
`
` AB
`
` AB
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`www.apotexcorp.com/products
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`photo not
`available
`
`photo not
`available
`
` 60505-2522-01
`
` 60 TABLET
`
` 60505-2522-01
`
` 60 TABLET
`
` 60505-6166-00
`
` 20ML INJECTABLE
`
` 60505-3532-05
`
` 500 TABLET
`
` 60505-3992-03
`
` 30 TABLET
`
` 60505-0253-02
`
` 90 TABLET
`
` 60505-0253-03
`
` 1000 TABLET
`
` 60505-3972-06
`
` 60 CAPSULE
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`11
`
`CIPLA LTD. EXHIBIT 2004 PAGE 14
`
`

`

`Apotex Products United States
`
`Updated April 29, 2020 All Products
`
`Product Name
`(Active Ingredients)
`
` Strength
`
` Brand Reference TE
`Rating
`
` Image
`(Not to Scale)
`
` NDC Number
`
` Pack Size
`
` 30MG
`
` AMRIX®
`
` AB
`
`Cyclosporine Capsules
`(Cyclosporine)
`
` 25MG
`
` NEORAL®
`
` AB1
`
` 50MG
`
` NEORAL®
`
` AB1
`
` 100MG
`
` NEORAL®
`
` AB1
`
`Cyclosporine Capsules USP
`(Cyclosporine)
`
` 25MG
`
` SANDIMMUNE®
`
` AB2
`
`
`
` SANDIMMUNE®
`
` AB2
`
` 100MG
`
` SANDIMMUNE®
`
` AB2
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 60505-3973-06
`
` 60 CAPSULE
`
` 60505-4630-03
`
` 30 LIQUID GEL
`CAPSULES UD
`
` 60505-4631-03
`
` 30 LIQUID GEL
`CAPSULES UD
`
` 60505-4632-03
`
` 30 LIQUID GEL
`CAPSULES UD
`
` 60505-0133-00
`
` 30 CAPSULE
`
` 60505-0133-00
`
` 30 CAPSULE
`
` 60505-0134-00
`
` 30 CAPSULE
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` SANDIMMUNE®
`
` AB2
`
`Desmopressin Acetate Tablets
`(Desmopressin Acetate)
`
` 0.1MG
`
` DDAVP®
`
` AB
`
`
`
` DDAVP®
`
` AB
`
` 0.2MG
`
` DDAVP®
`
` AB
`
`Diclofenac Sodium Topical Solution
`(Diclofenac Sodium)
`
` 1.5%
`
` PENNSAID®
`
` AT
`
`Dilt-XR (Diltiazem Hydrochloride
`Extended-Release Capsules USP)
`(Diltiazem HCl ER)
`
` 120MG
`
` DILACOR® XR
`
` AB2
`
`
`
`
`
` DILACOR® XR
`
` AB2
`
` DILACOR® XR
`
` AB2
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`www.apotexcorp.com/products
`
` 60505-0134-00
`
` 30 CAPSULE
`
` 60505-0257-01
`
` 100 TABLET
`
` 60505-0257-01
`
` 100 TABLET
`
` 60505-0258-01
`
` 100 TABLET
`
`
`
`
`
`
`
` 60505-0399-05
`
` 1 TOPICAL SOLUTION
`
` 60505-0014-06
`
` 100 CAPSULE
`
` 60505-0014-06
`
` 100 CAPSULE
`
` 60505-0014-08
`
` 500 CAPSULE
`
`
`
`
`
`
`
`12
`
`CIPLA LTD. EXHIBIT 2004 PAGE 15
`
`

`

`Apotex Products United States
`
`Updated April 29, 2020 All Products
`
`Product Name
`(Active Ingredients)
`
` Strength
`
` Brand Reference TE
`Rating
`
` Image
`(Not to Scale)
`
` NDC Number
`
` Pack Size
`
`
`
` DILACOR® XR
`
` AB2
`
` 180MG
`
` DILACOR® XR
`
` AB2
`
`
`
`
`
`
`
` DILACOR® XR
`
` AB2
`
` DILACOR® XR
`
` AB2
`
` DILACOR® XR
`
` AB2
`
` 240MG
`
` DILACOR® XR
`
` AB2
`
`
`
`
`
` DILACOR® XR
`
` AB2
`
` AB2
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 60505-0014-08
`
` 500 CAPSULE
`
` 60505-0015-06
`
` 100 CAPSULE
`
` 60505-0015-06
`
` 100 CAPSULE
`
` 60505-0015-08
`
` 500 CAPSULE
`
` 60505-0015-08
`
` 500 CAPSULE
`
` 60505-0016-06
`
` 100 CAPSULE
`
` 60505-0016-08
`
` 500 CAPSULE
`
` 60505-0016-08
`
` 500 CAPSULE
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` DILACOR® XR
`
`Doxazosin Mesylate Tablets
`(Doxazosin Maleate)
`
` 1MG
`
` CARDURA®
`
` AB
`
`
`
` 2MG
`
`
`
`
` 4MG
`
`
`
`
` 8MG
`
`
`
`
` 75MG
`
` CARDURA®
` CARDURA®
`
` CARDURA®
` CARDURA®
` CARDURA®
`
` CARDURA®
` CARDURA®
` CARDURA®
`
` CARDURA®
` CARDURA®
` ACTICLATE®
`
` AB
` AB
`
` AB
` AB
` AB
`
` AB
` AB
` AB
`
` AB
` AB
`
` AB
`
` 150MG
`
` ACTICLATE®
`
` AB
`
`Doxycycline Hyclate Tablets
`(Doxycycline Hyclate)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`www.apotexcorp.com/products
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 60505-0093-00
`
` 100 TABLET
`
` 60505-0093-01
` 60505-0094-00
`
` 1000 TABLET
` 100 TABLET
`
` 60505-0094-01
` 60505-0094-08
` 60505-0095-00
`
` 1000 TABLET
` 22500 TABLET
` 100 TABLET
`
` 60505-0095-01
` 60505-0095-05
` 60505-0096-00
`
` 1000 TABLET
` 11500 TABLET
` 100 TABLET
`
` 60505-0096-01
` 60505-0096-08
`
` 1000 TABLET
` 5000 TABLET
`
` 60505-4382-06
`
` 60 TABLET
`
` 60505-4384-06
`
` 60 TABLET
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`13
`
`CIPLA LTD. EXHIBIT 2004 PAGE 16
`
`

`

`Apotex Products United States
`
`Updated April 29, 2020 All Products
`
`Product Name
`(Active Ingredients)
`
` Strength
`
` Brand Reference TE
`Rating
`
` Image
`(Not to Scale)
`
` NDC Number
`
` Pack Size
`
`Drospirenone and Ethinyl Estradiol
`Tablets
`(Drospirenone/Ethinyl Estradiol)
`
`Duloxetine Delayed-Release
`Capsules
`(Duloxetine)
`
` 3/0.03MG
`
` YASMIN®
`
` AB
`
` 20MG
`
` CYMBALTA®
`
` AB
`
`
`
` CYMBALTA®
`
` AB
`
` 30MG
`
` CYMBALTA®
`
` AB
`
` 60MG
`
` CYMBALTA®
`
` AB
`
`
`
` CYMBALTA®
`
` AB
`
` 0.50MG
`
` AVODART®
`
` AB
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 60505-4183-03
`
` 3X28 TABLET
`
` 60505-2995-06
`
` 60 CAPSULE
`
` 60505-2995-06
`
` 60 CAPSULE
`
` 60505-2996-03
`
` 30 CAPSULE
`
` 60505-2997-03
`
` 30 CAPSULE
`
` 60505-2997-08
`
` 1000 CAPSULE
`
` 60505-3877-03
`
` 30 CAPSULE
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Dutasteride Capsules
`(Dutasteride)
`
`
`
` AVODART®
`
` AB
`
`Enoxaparin Sodium Injection
`(Enoxaparin)
`
` 30MG/0.3ML
`
` LOVENOX®
`
` AP
`
` 40MG/0.4ML
`
` LOVENOX®
`
` AP
`
` 60MG/0.6ML
`
` LOVENOX®
`
` AP
`
` 80MG/0.8ML
`
` LOVENOX®
`
` AP
`
` 100MG/ML
`
` LOVENOX®
`
` AP
`
` 120MG/0.8ML
`
` LOVENOX®
`
` AP
`
` 150MG/ML
`
` LOVENOX®
`
` AP
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 60505-3877-09
`
` 90 CAPSULE
`
` 60505-0791-04
`
` 10X0.3ML
`INJECTABLE
`
` 60505-0792-04
`
` 10X0.4ML
`INJECTABLE
`
` 60505-0793-04
`
` 10X0.6ML
`INJECTABLE UD
`
` 60505-0794-04
`
` 10X0.8ML
`INJECTABLE
`
`
`
`
`
`
`
`
`
`
`
` 60505-0795-04
`
` 10X1ML INJECTABLE
`
` 60505-0796-04
`
` 10X0.8ML
`INJECTABLE
`
`
`
` 60505-0798-04
`
` 10X1ML INJECTABLE
`
`www.apotexcorp.com/products
`
`14
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`CIPLA LTD. EXHIBIT 2004 PAGE 17
`
`

`

`Apotex Products United States
`
`Updated April 29, 2020 All Products
`
`Product Name
`(Active Ingredients)
`
` Strength
`
` Brand Reference TE
`Rating
`
` Image
`(Not to Scale)
`
` NDC Number
`
` Pack Size
`
`Epinastine HCl Ophthalmic
`Solution
`(Epinastine Hydrochloride)
`
` 0.05%
`
` ELESTAT®
`
` AT
`
`Eplerenone Tablets
`(Eplerenone)
`
` 25MG
`
` INSPRA®
`
` AB
`
` 50MG
`
` INSPRA®
`
` AB
`
`Ertapenem for Injection
`(Ertapenem)
`
` 1G
`
` INVANZ®
`
` AP
`
`Etodolac Capsules USP
`(Etodolac)
`
` 200MG
`
` LODINE®
`
` AB
`
`
`
` LODINE®
`
` AB
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 60505-0584-01
`
` 5ML OPHTHALMIC
`SOLUTION
`
` 60505-2651-09
`
` 90 TABLET
`
` 60505-2652-09
`
` 90 TABLET
`
` 60505-6196-04
`
` 10 INJECTABLE
`
` 60505-0039-01
`
` 100 CAPSULE
`
` 60505-0039-01
`
` 100 CAPSULE
`
` 100 CAPSULE
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 300MG
`
` LODINE®
`
` AB
`
` 60505-0040-01
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` LODINE®
`
` AB
`
`Etodolac Tablets
`(Etodolac)
`
` 400MG
`
` LODINE®
`
` AB
`
`
`
` LODINE®
`
` AB
`
` 500MG
`
` LODINE®
`
` AB
`
`
`
` LODINE®
`
` AB
`
`Ezetimibe Tablets
`(Ezetimibe)
`
` 10MG
`
` ZETIA®
`
`
`
` ZETIA®
`
` AB
`
` AB
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`www.apotexcorp.com/products
`
` 60505-0040-01
`
` 100 CAPSULE
`
` 60505-0041-01
`
` 100 TABLET
`
` 60505-0041-01
`
` 100 TABLET
`
` 60505-0102-01
`
` 100 TABLET
`
` 60505-0102-01
`
` 100 TABLET
`
` 60505-2945-03
`
` 30 TABLET
`
` 60505-2945-03
`
` 30 TABLET
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`15
`
`CIPLA LTD. EXHIBIT 2004 PAGE 18
`
`

`

`Apotex Products United States
`
`Updated April 29, 2020 All Products
`
`Product Name
`(Active Ingredients)
`
` Strength
`
` Brand Reference TE
`Rating
`
` Image
`(Not to Scale)
`
` NDC Number
`
` Pack Size
`
`
`
`
`
`
`
`
`
` ZETIA®
`
` ZETIA®
`
` ZETIA®
`
` ZETIA®
`
` AB
`
` AB
`
` AB
`
` AB
`
`Famciclovir Tablets
`(Famciclovir)
`
` 125MG
`
` FAMVIR®
`
` AB
`
`
`
` FAMVIR®
`
` AB
`
` 250MG
`
` FAMVIR®
`
` AB
`
`
`
` FAMVIR®
`
` AB
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 60505-2945-09
`
` 90 TABLET
`
` 60505-2945-09
`
` 90 TABLET
`
` 60505-2945-05
`
` 500 TABLET
`
` 60505-2945-05
`
` 500 TABLET
`
` 60505-3245-03
`
` 30 TABLET
`
` 60505-3245-03
`
` 30 TABLET
`
` 60505-3246-03
`
` 30 TABLET
`
` 60505-3246-03
`
` 30 TABLET
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 500MG
`
` FAMVIR®
`
` AB
`
` 60505-3247-03
`
` 30 TABLET
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` FAMVIR®
`
` AB
`
`Fenofibrate Capsules
`(Fenofibrate)
`
` 43MG
`
` ANTARA®
`
` AB
`
`
`
` ANTARA®
`
` 130MG
`
` ANTARA®
`
`
`
`
`
`
`
` AB
`
` AB
`
` AB
`
` AB
`
` ANTARA®
`
` ANTARA®
`
` ANTARA®
`
` AB
`
`Fentanyl Transdermal System
`(Fentanyl)
`
` 12MCG/HR
`
` DURAGESIC®
`
` AB
`
`www.apotexcorp.com/products
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 60505-3247-03
`
` 30 TABLET
`
` 60505-3120-03
`
` 30 CAPSULE
`
` 60505-3120-03
`
` 30 CAPSULE
`
` 60505-3121-03
`
` 30 CAPSULE
`
` 60505-3121-03
`
` 30 CAPSULE
`
` 60505-3121-09
`
` 90 CAPSULE
`
` 60505-3121-09
`
` 90 CAPSULE
`
` 60505-7010-02
`
` 5 PATCH
`
`photo not
`available
`
`photo not
`available
`
`photo not
`available
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`16
`
`CIPLA LTD. EXHIBIT 2004 PAGE 19
`
`

`

`Apotex Products United States
`
`Updated April 29, 2020 All Products
`
`Product Name
`(Active Ingredients)
`
` Strength
`
` Brand Reference TE
`Rating
`
` Image
`(Not to Scale)
`
` NDC Number
`
` Pack Size
`
`
`
` DURAGESIC®
`
` AB
`
` 25MCG/HR
`
` DURAGESIC®
`
` AB
`
`
`
` DURAGESSIC®
`
` AB
`
` 37.5MCG/HR
`
` DURAGESIC®
`
` AB
`
` 50MCG/HR
`
` DURAGESIC®
`
` AB
`
`
`
` DURAGESIC®
`
` AB
`
` 62.5MCG/HR
`
` DURAGESIC®
`
` AB
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 60505-7080-02
`
` 5 PATCH
`
` 60505-7006-02
`
` 5 PATCH
`
` 60505-7081-02
`
` 5 PATCH
`
` 60505-7085-02
`
` 5 PATCH
`
` 60505-7007-02
`
` 5 PATCH
`
` 60505-7082-02
`
` 5 PATCH
`
` 60505-7086-02
`
` 5 PATCH
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 75MCG/HR
`
` DURAGESIC®
`
` AB
`
`
`
` DURAGESIC®
`
` AB
`
` 87.5MCG/HR
`
` DURAGESIC®
`
` AB
`
` 100MCG/HR
`
` DURAGESIC®
`
` AB
`
`
`
` DURAGESIC®
`
` AB
`
`Fluticasone Propionate Nasal Spray
`(Fluticasone Propionate)
`
` 50MCG
`
` FLONASE®
`
` AB
`
`Fluvoxamine Maleate Tablets USP
`(Fluvoxamine Maleate)
`
` 25MG
`
` LUVOX®
`
` AB
`
`
`
` LUVOX®
`
` AB
`
`www.apotexcorp.com/products
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 60505-7008-02
`
` 5 PATCH
`
` 60505-7083-02
`
` 5 PATCH
`
` 60505-7087-02
`
` 5 PATCH
`
` 60505-7009-02
`
` 5 PATCH
`
` 60505-7084-02
`
` 5 PATCH
`
`
`
`
`
`
`
`
`
` 60505-0829-01
`
` 15ML NASAL SPRAY
`
` 60505-0164-01
`
` 100 TABLET
`
` 60505-0164-01
`
` 100 TABLET
`
`
`
`
`
`17
`
`CIPLA LTD. EXHIBIT 2004 PAGE 20
`
`

`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Apotex Products United States
`
`Updated April 29, 2020 All Products
`
`Product Name
`(Active Ingredients)
`
` Strength
`
` Brand Reference TE
`Rating
`
` Image
`(Not to Scale)
`
` NDC Number
`
` Pack Size
`
` 50MG
`
` LUVOX®
`
` AB
`
` 100MG
`
` LUVOX®
`
` AB
`
`
`
` LUVOX®
`
` AB
`
`Fosaprepitant for Injection
`(Fosaprepitant)
`
` 150MG
`
` EMEND®
`
` AP
`
`Gabapentin Capsules
`(Gabapentin)
`
` 100MG
`
` NEURONTIN®
`
` AB
`
`
`
`
` 300MG
`
` NEURONTIN®
` NEURONTIN®
` NEURONTIN®
`
` AB
` AB
` AB
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 60505-0165-01
`
` 100 TABLET
`
` 60505-0166-01
`
` 100 TABLET
`
` 60505-0166-01
`
` 100 TABLET
`
` 60505-6105-01
`
` 1 INJECTABLE
`
` 60505-0112-00
`
` 100 CAPSULE UD
`
` 60505-0112-01
` 60505-0112-08
` 60505-0113-00
`
` 100 CAPSULE
` 1000 CAPSULE
` 100 CAPSULE UD
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Gabapentin Tablets
`(Gabapentin)
`
`Galantamine Tablets
`(Galantamine HBr)
`
` NEURONTIN®
` NEURONTIN®
` NEURONTIN®
`
` NEURONTIN®
` NEURONTIN®
` NEURONTIN®
`
` NEURONTIN®
` NEURONTIN®
`
` NEURONTIN®
` RAZADYNE®
`
` AB
` AB
` AB
`
` AB
` AB
`
` AB
`
` AB
` AB
`
` AB
`
` AB
`
` 400MG
`
`
`
`
` 600MG
`
`
`
` 800MG
`
`
`
` 4MG
`
` 8MG
`
` RAZADYNE®
`
` AB
`
` 12MG
`
` RAZADYNE®
`
` AB
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`www.apotexcorp.com/products
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 60505-0113-01
` 60505-0113-08
` 60505-0114-00
`
` 100 CAPSULE
` 1000 CAPSULE
` 100 CAPSULE UD
`
` 60505-0114-01
` 60505-0114-05
`
` 100 CAPSULE
` 500 CAPSULE
`
` 60505-2551-01
`
` 100 TABLET
`
` 60505-2551-05
` 60505-2552-01
`
` 500 TABLET
` 100 TABLET
`
` 60505-2552-05
`
` 500 TABLET
`
` 60505-2542-06
`
` 60 TABLET
`
` 60505-2543-06
`
` 60 TABLET
`
` 60505-2544-06
`
` 60 TABLET
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`18
`
`CIPLA LTD. EXHIBIT 2004 PAGE 21
`
`

`

`Apotex Products United States
`
`Updated April 29, 2020 All Products
`
`Product Name
`(Active Ingredients)
`
` Strength
`
` Brand Reference TE
`Rating
`
` Image
`(Not to Scale)
`
` NDC Number
`
` Pack Size
`
`Gemcitabine Injection
`(Gemicitabine)
`
` 38MG/ML
`
` GEMCITABINE®
`
` AP
`
`
`
`
`
` GEMCITABINE®
`
` AP
`
` GEMCITABINE®
`
` AP
`
`Glipizide Tablets USP
`(Glipizide)
`
` 5MG
`
` GLUCOTROL®
`
` AB
`
`
`
`
`
` GLUCOTROL®
`
` AB
`
` GLUCOTROL®
`
` AB
`
`
`
`
`
`
`
`
`
`
`
`
`
` 60505-6113-06
`
` 5ML INJECTABLE
`
` 60505-6114-00
`
` 26ML INJECTABLE
`
` 60505-6115-02
`
` 50ML INJECTABLE
`
` 60505-0141-00
`
` 100 TABLET
`
` 60505-0141-02
`
` 500 TABLET
`
` 60505-0141-01
`
` 1000 TABLET
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 10MG
`
` GLUCOTROL®
`
` AB
`
`
`
`
`
` GLUCOTROL®
`
` AB
`
` GLUCOTROL®
`
` AB
`
`Guanfacine Extended-Release
`Tablets
`(Guanfacine)
`
` 1MG
`
` INTUNIV®
`
` AB
`
`
`
` INTUNIV®
`
` AB
`
` 2MG
`
` INTUNIV®
`
` AB
`
`
`
` INTUNIV®
`
` AB
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`www.apotexcorp.com/products
`
` 60505-0142-00
`
` 100 TABLET
`
` 60505-0142-02
`
` 500 TABLET
`
` 60505-0142-01
`
` 1000 TABLET
`
` 60505-3927-01
`
` 100 TABLET
`
` 60505-3927-01
`
` 100 TABLET
`
` 60505-3928-01
`
` 100 TABLET
`
` 60505-3928-01
`
` 100 TABLET
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`19
`
`CIPLA LTD. EXHIBIT 2004 PAGE 22
`
`

`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Apotex Products United States
`
`Updated April 29, 2020 All Products
`
`Product Name
`(Active Ingredients)
`
` Strength
`
` Brand Reference TE
`Rating
`
` Image
`(Not to Scale)
`
` NDC Number
`
` Pack Size
`
` 3MG
`
` INTUNIV®
`
` AB
`
`
`
` INTUNIV®
`
` AB
`
` 4MG
`
` INTUNIV®
`
` AB
`
`
`
` INTUNIV®
`
` AB
`
`Ibandronate Sodium Injection
`(Ibandronate Sodium)
`
` 3MG/3ML
`
` BONIVA®
`
` AP
`
`Ibandronate Sodium Tablet
`(Ibandronate Sodium)
`
` 150MG
`
` BONIVA®
`
` AB
`
`
`
`
`
`
`
`
`
`
`
`
`
` 60505-3929-01
`
` 100 TABLET
`
` 60505-3929-01
`
` 100 TABLET
`
` 60505-3930-01
`
` 100 TABLET
`
` 60505-3930-01
`
` 100 TABLET
`
` 60505-6097-00
`
` 3ML INJECTABLE
`
` 60505-2795-00
`
` 3 TABLET
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Ibandronate Sodium Tablets
`(Ibandronate Sodium)
`
` 150MG
`
` BONIVA®
`
` AB
`
`Imatinib Mesylate Tablets
`(Imatinib Mesylate)
`
` 100MG
`
` GLEEVEC®
`
` AB
`
`
`
` GLEEVEC®
`
` AB
`
` 400MG
`
` GLEEVEC®
`
` AB
`
`
`
` GLEEVEC®
`
` AB
`
`Irinotecan Hydrochloride Injection
`(Irinotecan HCL)
`
` 20MG/ML
`
` CAMPTOSAR®
`
` AP
`
`
`
` CAMPTOSAR®
`
` AP
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`www.apotexcorp.com/products
`
` 60505-2795-00
`
` 3 TABLET
`
` 60505-2900-09
`
` 90 TABLET
`
` 60505-2900-09
`
` 90 TABLET
`
` 60505-2901-03
`
` 30 TABLET
`
` 60505-2901-03
`
` 30 TABLET
`
` 60505-6128-00
`
` 2ML INJECTABLE
`
` 60505-6128-01
`
` 5ML INJECTABLE
`
`
`
`
`
`
`
`
`
`
`
`
`
`20
`
`CIPLA LTD. EXHIBIT 2004 PAGE 23
`
`

`